NCBiotech Company Directory is a comprehensive listing of North Carolina's life science industry New search

Avolynt Inc.

Avolynt is developing a novel SGLT2 inhibitor for the treatment of nonalcoholic steatohepatitis (NASH) and type 2 diabetes.

Company location

3200 E. Highway 54, Suite 100
Research Triangle Park, NC 27709
Phone 
(919) 659-5677
County 
Durham
Region 
Triangle

Company Classification

Company type 
Bioscience Company
Year founded 
2015
Employment in NC 
1-19
US headquarters 
North Carolina
Global headquarters 
United States
Company activities 
Research and Development